Skip to main content

Research Repository

Advanced Search

⁹⁹ᵐTc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation

Stasiuk, Graeme J.; Holloway, Paul M.; Rivas, Charlotte; Trigg, William; Luthra, Sajinder Kaur; Morrison Iveson, Veronique; Gavins, Felicity N.E.; Long, Nicholas J.

Authors

Graeme J. Stasiuk

Paul M. Holloway

Charlotte Rivas

William Trigg

Sajinder Kaur Luthra

Veronique Morrison Iveson

Felicity N.E. Gavins

Nicholas J. Long



Abstract

Non-invasive imaging of the inflammatory process can provide a great deal of insight into a wide variety of diseases states, aiding diagnosis, evaluation and effective targeted treatment. During inflammation, blood borne leukocytes are recruited, through a series of activation and adhesion steps, to the site of injury or infection where they migrate across the blood vessel wall into the tissue. Thus, tracking leukocyte recruitment and accumulation provides a dynamic and localised read out of inflammatory events. Current leukocyte imaging techniques require ex vivo labelling of patient blood, involving laborious processing and potential risks to both patient and laboratory staff. Utilising high affinity ligands for leukocyte specific receptors may allow for injectable tracers that label leukocytes in situ, omitting potentially hazardous ex vivo handling. Formyl peptide receptors (FPRs) are a group of G-protein coupled receptors involved in the chemotaxis and inflammatory functioning of leukocytes. Highly expressed on leukocytes, and up regulated during inflammation, these receptors provide a potential target for imaging inflammatory events. Herein we present the synthesis and initial in vitro testing of a potential Single Photon Emission Computed Tomography (SPECT) leukocyte tracer. The FPR1 antagonist cFLFLFK-NH₂, which displays high affinity with little physiological effect, has been linked via a PEG motif to a ⁹⁹ᵐTc chelate. This tracer shows in vitro binding to human embryonic kidney cells expressing the FPR1 receptor, and functional in vitro tests reveal cFLFLFK-NH₂ compounds to have no effect on inflammatory cell functioning. Overall, these data show that ⁹⁹ᵐTc.cFLFLFK-NH₂ may be a useful tool for non-invasive imaging of leukocyte accumulation in inflammatory disease states.

Citation

Stasiuk, G. J., Holloway, P. M., Rivas, C., Trigg, W., Luthra, S. K., Morrison Iveson, V., …Long, N. J. (2015). ⁹⁹ᵐTc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation. Dalton Transactions : an international journal of inorganic chemistry, 44(11), 4986-4993. https://doi.org/10.1039/c4dt02980a

Journal Article Type Article
Acceptance Date Jan 7, 2015
Online Publication Date Jan 7, 2015
Publication Date Jan 1, 2015
Deposit Date Feb 23, 2016
Publicly Available Date Mar 28, 2024
Journal Dalton transactions
Print ISSN 1477-9226
Electronic ISSN 1477-9234
Publisher Royal Society of Chemistry
Peer Reviewed Peer Reviewed
Volume 44
Issue 11
Pages 4986-4993
DOI https://doi.org/10.1039/c4dt02980a
Keywords ⁹⁹ᵐTc SPECT imaging; Inflammation
Public URL https://hull-repository.worktribe.com/output/411133
Publisher URL http://pubs.rsc.org/en/Content/ArticleLanding/2015/DT/c4dt02980a#!divAbstract
Additional Information This is the authors accepted manuscript of an article published in Dalton transactions, 2015, v.44 issue 11.

Files





You might also like



Downloadable Citations